Paper330174
Catecholamine receptors on locus coeruleus neurons: pharmacological characterization.
Cedarbaum JM and 1 other. Eur J Pharmacol, 1977. Cited by 519 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Papers, record 330174. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/330174
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cerebral Ventricles | Major topic |
| Neurons | Major topic |
| Receptors, Adrenergic | Major topic |
| Action Potentials | |
| Animals | |
| Apomorphine | |
| Clonidine | |
| Dopamine | |
| Epinephrine | |
| Iontophoresis | |
| Isoproterenol | |
| Male | |
| Nordefrin | |
| Norepinephrine | |
| Phenylephrine | |
| Piperoxan | |
| Rats | |
| Sotalol | |
| Trifluoperazine | |
| gamma-Aminobutyric Acid |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT05109364 | Terazosin and Parkinson's Disease Extension Study | Results | ClinicalTrials.gov | |
| NCT05712707 | Sublingual Dexmedetomidine for Treating Opioid Withdrawal | Background | ClinicalTrials.gov |
Cited by80
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 519 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,921,050 | tDCS cranial nerve Co-stimulation: Unveiling brainstem pathways involved in trigeminal nerve direct current stimulation in rats. | Brain Stimul | 2025 | https://conductscience.org/library/papers/39921050 | PubMed |
| 39,211,395 | Occlusal effects on text reading: an eye-tracker study. | Front Syst Neurosci | 2024 | https://conductscience.org/library/papers/39211395 | PubMed |
| 38,389,787 | Grid cells: the missing link in understanding Parkinson's disease? | Front Neurosci | 2024 | https://conductscience.org/library/papers/38389787 | PubMed |
| 37,680,715 | Combined α2- and D2-receptor blockade activates noradrenergic and dopaminergic neurons, but extracellular dopamine in the prefrontal cortex is determined by uptake and release from noradrenergic terminals. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37680715 | PubMed |
| 37,626,803 | Trigeminal Stimulation and Visuospatial Performance: The Struggle between Chewing and Trigeminal Asymmetries. | Biomedicines | 2023 | https://conductscience.org/library/papers/37626803 | PubMed |
| 36,918,712 | Altered norepinephrine transmission after spatial learning impairs sleep-mediated memory consolidation in rats. | Sci Rep | 2023 | https://conductscience.org/library/papers/36918712 | PubMed |
| 36,674,992 | Alpha2-Adrenergic Receptors as a Pharmacological Target for Spike-Wave Epilepsy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36674992 | PubMed |
| 34,624,301 | Corticotropin releasing factor and norepinephrine related circuitry changes in the bed nucleus of the stria terminalis in stress and alcohol and substance use disorders. | Neuropharmacology | 2021 | https://conductscience.org/library/papers/34624301 | PubMed |
| 32,445,638 | Bidirectional pharmacological perturbations of the noradrenergic system differentially affect tactile detection. | Neuropharmacology | 2020 | https://conductscience.org/library/papers/32445638 | PubMed |
| 28,615,331 | Comparison of the VTA and LC response to methylphenidate: a concomitant behavioral and neuronal study of adolescent male rats. | J Neurophysiol | 2017 | https://conductscience.org/library/papers/28615331 | PubMed |
| 25,761,840 | Noradrenergic modulation of risk/reward decision making. | Psychopharmacology (Berl) | 2015 | https://conductscience.org/library/papers/25761840 | PubMed |
| 25,759,403 | Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons. | J Psychopharmacol | 2015 | https://conductscience.org/library/papers/25759403 | PubMed |
| 25,664,335 | Chronic Stimulation of Alpha-2A-Adrenoceptors With Guanfacine Protects Rodent Prefrontal Cortex Dendritic Spines and Cognition From the Effects of Chronic Stress. | Neurobiol Stress | 2015 | https://conductscience.org/library/papers/25664335 | PubMed |
| 23,341,594 | Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23341594 | PubMed |
| 22,990,678 | Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists. | J Neural Transm (Vienna) | 2013 | https://conductscience.org/library/papers/22990678 | PubMed |
| 22,461,743 | Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale. | Yale J Biol Med | 2012 | https://conductscience.org/library/papers/22461743 | PubMed |
| 22,408,604 | Physiology of quantal norepinephrine release from somatodendritic sites of neurons in locus coeruleus. | Front Mol Neurosci | 2012 | https://conductscience.org/library/papers/22408604 | PubMed |
| 21,931,808 | The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study. | PLoS One | 2011 | https://conductscience.org/library/papers/21931808 | PubMed |
| 20,925,474 | The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder. | Expert Rev Neurother | 2010 | https://conductscience.org/library/papers/20925474 | PubMed |
| 20,596,295 | The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex. | J Pediatr | 2009 | https://conductscience.org/library/papers/20596295 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| TERAZOSIN | CHEMBL611 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL611 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/330174
GET https://conductscience.org/api/papers/v1/330174/cited_by?page=2